Northern Irish writer Anna Burns wins 2018 Booker Prize

Agencies
October 17, 2018

London, Oct 17: Author Anna Burns has won the Man Booker Prize for her novel 'Milkman', becoming the first author from Northern Ireland to win the most prestigious English-language literary award.

Burns, 56, who was born in Belfast, is the 17th woman to bag the award in its 49-year history and the first woman since 2013. It was her third novel.

'Milkman', a coming of age story of a young woman's affair with a married man set in the political troubles of Northern Ireland, was named the winner at a lavish awards ceremony here on Tuesday night.

"None of us has ever read anything like this before. Anna Burns' utterly distinctive voice challenges conventional thinking and form in surprising and immersive prose," said Kwame Anthony Appiah, the chair of the 2018 judging panel.

"It is a story of brutality, sexual encroachment and resistance threaded with mordant humour. Set in a society divided against itself, 'Milkman' explores the insidious forms oppression can take in everyday life," he said.

The recipient of the Man Booker Prize gets 52,500 pounds (USD 69,223 or Rs 50.85 lakh).

Burns, who lives in East Sussex in England, saw off competition from two British writers, two American writers and one Canadian writer.

Set in an unnamed city, 'Milkman' focuses on a "middle sister" as she navigates her way through rumour, social pressures and politics in a tight-knit community.

Burns shows the dangerous and complex impact on a woman coming of age in a city at war.

Unusually, in the book, the characters have designations rather than names.

Burns explains: "The book didn't work with names. It lost power and atmosphere and turned into a lesser — or perhaps just a different — book.

"In the early days I tried out names a few times, but the book wouldn't stand for it. The narrative would become heavy and lifeless and refuse to move on until I took them out again. Sometimes the book threw them out itself".

Her novel beat competition from 'Everything Under' by Daisy Johnson, who, at 27, was the youngest nominee in the Man Booker prize history.

The other nominees were 'The Long Take' by Robin Robertson, 'Washington Black' by Esi Edugyan, 'The Mars Room' by Rachel Kushner, and 'The Overstory' by Richard Powers.

'Milkman' is published by Faber & Faber, making it the fourth consecutive year the prize has been won by an independent publisher.

Burns' win was announced by Kwame Anthony Appiah at a dinner at London's Guildhall. She was presented with a trophy by Camilla, the Duchess of Cornwall, and a 50,000 pounds cheque by Luke Ellis, Chief Executive of Man Group.

The winning author also receives a designer bound edition of her book and a further 2,500 pounds for being short-listed.

"We are honoured to support the Man Booker Prize for the sixteenth year, as it continues in its fiftieth year to champion literary excellence and the power of the novel on a global scale," Ellis said.

Appiah, a British-born Ghanaian-American novelist, was joined on the 2018 judging panel by crime writer Val McDermid; cultural critic Leo Robson; feminist writer and critic Jacqueline Rose; and artist and graphic novelist Leanne Shapton.

The judges considered 171 submissions for this year's prize.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 6,2020

Beijing, Feb 6: The number of confirmed fatalities from China's coronavirus outbreak rose to at least 560, after authorities in hardest-hit Hubei province reported 70 new deaths on February 6.

In its daily update, the health commission in Hubei also confirmed the number of confirmed infections in the outbreak has reached 28,018 nationwide with 3,694 new cases reported.

The epidemic, which has spiralled into a global health emergency, is believed to have emerged in December from a market that sold wild game in Hubei's capital Wuhan.

Hu Lishan, an official in Wuhan, warned Wednesday that despite building a hospital from scratch and converting public buildings to accommodate thousands of extra patients, there was still a "severe" lack of beds in the region.

There was also a shortage of "equipment and materials," he told reporters, adding that officials were looking to convert other hotels and schools in the city into treatment centres.

Authorities in several other cities in China have placed restrictions on the number of people allowed to leave their homes.

Global concerns have also risen about the virus, with cases confirmed in more than 20 countries.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

London, Mar 25: Prince Charles on Wednesday has tested positive for the novel coronavirus and is working from home with mild symptoms, according to UK media.
A Clarence House spokesperson said the Prince of Wales was "displaying mild symptoms but otherwise remains in good health and has been working from home throughout the last few days as usual", the Telegraph UK reported.
"He has been displaying mild symptoms but otherwise remains in good health and has been working from home throughout the last few days as usual," the spokesperson added.
In accordance with the government and medical advice, the 71-year old heir to the British throne and Camilla, the Duchess of Cornwall, are now self-isolating at their home in Scotland.
The Duchess of Cornwall has also been tested but does not have the virus.
The tests were carried out by the NHS in Aberdeenshire where they met the criteria required for testing.
"It is not possible to ascertain from whom the Prince caught the virus owing to the high number of engagements he carried out in his public role during recent weeks," the statement further said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Paris, Apr 10: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could be a potential weapon against novel coronavirus, across 50 countries.

The company has already doubled its incremental production capacity on top of the usual production for current indications across its eight hydroxychloroquine manufacturing sites worldwide and is on track to quadruple it by the summer.

"In this global health emergency, Sanofi stands ready to assist as many countries as possible, starting with countries where its medicine is registered for current approved indications as well as countries where there are no hydroxychloroquine suppliers or countries with underserved populations," it said in a statement.

Sanofi called for coordination among the entire hydroxychloroquine chain worldwide to ensure the continued supply of the medicine if proven to be a well-tolerated and effective treatment in COVID-19 patients.

"The COVID-19 pandemic is an unprecedented health and economic crisis which is shaking some of the very fundamentals of international solidarity and cooperation among countries," said Chief Executive Officer Paul Hudson. "This virus does not care about the concept of borders, so we should not either," he added.

"It is critical that international authorities, local governments, manufacturers and all other players involved in the hydroxychloroquine chain work together in a coordinated manner to ensure all patients who may benefit from this potential treatment can access it. If the trials prove positive, we hope our donation will play a critical role for patients," said Hudson.

While hydroxychloroquine is generating a lot of hope for patients around the world, said Sanofi, it should be remembered that there are no results from ongoing studies and the results may be positive or negative.

To date, there is insufficient clinical evidence to draw any conclusion over the safety and efficacy of hydroxychloroquine in the management of COVID-19 patients.

It is one of several medicines being investigated by the World Health Organisation (WHO) in its international clinical trial seeking a treatment solution for COVID-19. "Sanofi is supporting ongoing trials by providing the medicine to some participating investigator sites and other independent research centres," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.